- Home
- VTAK vs VERO Comparison
VTAK vs VERO Comparison
Compare VTAK & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- VERO
- Stock Information
- Founded
- VTAK 2002
- VERO N/A
- Country
- VTAK United States
- VERO Canada
- Employees
- VTAK N/A
- VERO N/A
- Industry
- VTAK Medical/Dental Instruments
- VERO Medical/Dental Instruments
- Sector
- VTAK Health Care
- VERO Health Care
- Exchange
- VTAK Nasdaq
- VERO Nasdaq
- Market Cap
- VTAK 3.9M
- VERO 4.5M
- IPO Year
- VTAK 2018
- VERO N/A
- Fundamental
- Price
- VTAK $3.04
- VERO $2.45
- Analyst Decision
- VTAK
- VERO
- Analyst Count
- VTAK 0
- VERO 0
- Target Price
- VTAK N/A
- VERO N/A
- AVG Volume (30 Days)
- VTAK 3.1M
- VERO 29.2K
- Earning Date
- VTAK 08-11-2025
- VERO 08-14-2025
- Dividend Yield
- VTAK N/A
- VERO N/A
- EPS Growth
- VTAK N/A
- VERO N/A
- EPS
- VTAK N/A
- VERO N/A
- Revenue
- VTAK $600,000.00
- VERO $60,107,000.00
- Revenue This Year
- VTAK $822.86
- VERO N/A
- Revenue Next Year
- VTAK $168.42
- VERO $7.47
- P/E Ratio
- VTAK N/A
- VERO N/A
- Revenue Growth
- VTAK 37.62
- VERO N/A
- 52 Week Low
- VTAK $2.49
- VERO $2.10
- 52 Week High
- VTAK $43.70
- VERO $14.50
- Technical
- Relative Strength Index (RSI)
- VTAK 44.02
- VERO 49.47
- Support Level
- VTAK $2.70
- VERO $2.24
- Resistance Level
- VTAK $4.31
- VERO $2.47
- Average True Range (ATR)
- VTAK 0.37
- VERO 0.10
- MACD
- VTAK 0.03
- VERO -0.00
- Stochastic Oscillator
- VTAK 30.22
- VERO 67.74
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.